Emily Leproust

New Capabilities

As of August 2026: Leading the US DNA synthesis company's AI-drug-discovery services

Artificial intelligence can design tens of thousands of antibody candidates in days. Turning those digital sequences into physical molecules for testing still takes months. PROTEINA and Twist Bioscience announced a partnership on August 27, 2026, to collapse that gap.

Updated Aug 27